Navigation Links
In Men, Duration of Diabetes Linked to Raised Heart Risk
Date:3/14/2011

By Amanda Gardner
HealthDay Reporter

MONDAY, March 14 (HealthDay News) -- When a man develops type 2 diabetes could determine his risk of a heart attack, a new study finds.

In fact, men who have had type 2 diabetes for a decade or more face the same risk as those who have already had a prior heart attack, the researchers found.

The findings, appearing this week in the March 14 issue of Archives of Internal Medicine, may help to stratify patients based on risk level, to better determine who needs what type of care and when.

"You don't want to give all these big, powerful, expensive medicines to every single person. Maybe we can tease out the group that would benefit more," said Dr. Robert Scott III, an associate professor of internal medicine at Texas A&M Health Science Center College of Medicine and senior staff cardiologist at Scott & White in Temple, Texas. He was not involved in the new study.

Prior research had indicated that the risk of heart disease in people with type 2 diabetes was the same as in people who had had a previous heart attack. But this research indicates that the risk really does have more to do with timing.

After following about 4,000 men aged 60 to 79 for nine years, British researchers led by S. Goya Wannamethee of University College London, found a higher risk of heart attacks and death in all those who had diabetes, compared to men who didn't have the illness.

Risk rose along with duration of disease -- compared to men without diabetes, men who had early-onset diabetes (in this case, for an average of 17 years or more) had 2.5 times the risk of a heart attack. That level of risk was equal to that of men with a prior history of heart attack, the team noted.

Men who had late-onset diabetes (an average of five years with the disease) had a 54 percent increased risk of a heart attack or of dying.

The risk for cardiovascular problems ro
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Postpartum intervention/support prevents smoking relapse, extends breastfeeding duration
2. Short nighttime sleep duration among infants, young children associated with obesity in later life
3. Study finds an increased risk of death in men with insomnia and a short sleep duration
4. Study links shorter sleep durations with greater risks of mental distress in young adults
5. Short and long sleep durations are independent risk factors for cardiovascular disease
6. First-time parents daily sleep duration predicts their relationship satisfaction
7. Southeastern States Mired in the Diabetes Belt: CDC Report
8. Diabetes Often Not Diagnosed or Treated Properly
9. Diabetes Ups Death Risk Overall, Study Shows
10. Potassium levels possible key to racial disparity in Type 2 diabetes
11. Scientists Spot Another Gene Behind Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
In Men, Duration of Diabetes Linked to Raised Heart Risk
(Date:7/29/2015)... ... ... Today marks a significant achievement in bringing new monies into early stage companies. ... a group of experienced investors, has tapped into an investor community passionate about Sofia’s ... part of the fund. The Sofia Fund II is now closed to investors, ...
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... ... Petitions were approved by USCIS over the past month! I-829 approvals have been granted ... projects in Los Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a prominent orthopedic ... treatments to qualifying patients with demonstrated financial need. , “We are thrilled for ...
(Date:7/29/2015)... AL (PRWEB) , ... July 29, 2015 , ... Employee ... directory will include the general contact information, website, types of plans administered, years in ... their business listing and have at least one plan with Employee Fiduciary. A search ...
(Date:7/29/2015)... ... 29, 2015 , ... TransFlip is an all new dynamic transition pack for ... FCPX, these transitions are easy to apply and modify for any skill-level user. TransFlip ... 60 preset styles, kinetic flipping panel animations are just a few clicks away. , ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2
... Maureen Salamon HealthDay Reporter , THURSDAY, April 28 ... in her early forties when she developed anorexia nervosa, and ... the middle of a disorder like that, you don,t know ... said. Luckily, Hodgin sought the care of a therapist ...
... arthritis may find themselves taking on a more active role ... an ongoing relationship with a primary healthcare (PHC) provider, according ... current issue of Medical Care , the study is ... a regular primary healthcare provider and patient activation, a growing ...
... MD The Association for Research in Vision and ... of distinguished fellows. The title of Fellow of ARVO ... to the Association. By accepting this honor, ARVO ... models and mentors for individuals pursuing careers in vision ...
... Association for Research in Vision and Ophthalmology (ARVO) is pleased ... will be acknowledged at the ARVO 2011 Annual Meeting, May ... Medal: Robert E. Anderson, MD, PhD, FARVO, Mildred Weisenfeld Award ... FEBOpht, FARVO, Friedenwald Award: James T. Rosenbaum, MD, FARVO, Cogan ...
... during proton treatments for pediatric cancer patients provides for ... radiation compared to standard diagnostic X-rays and cone beam ... Cancer Imaging and Radiation Therapy Symposium in Atlanta. The ... Oncology (ASTRO) and the Radiological Society of North America ...
... with fluorodeoxyglucose positron emission tomography (FDG-PET) images results ... different treatment options in head and neck cancer ... research presented today, at the Cancer Imaging and ... co-sponsored by the American Society for Radiation Oncology ...
Cached Medicine News:Health News:Bringing Partner Into Anorexia Treatment May Aid Recovery 2Health News:Bringing Partner Into Anorexia Treatment May Aid Recovery 3Health News:Ongoing relationship with care provider key for patients with a chronic condition: UBC study 2Health News:2011 ARVO Fellows announced 2Health News:2011 ARVO Award recipients honored at annual meeting 2Health News:2011 ARVO Award recipients honored at annual meeting 3Health News:Proton imaging provides more accuracy, less radiation to pediatric cancer patients 2
(Date:7/29/2015)... , July 29, 2015  Cepheid (Nasdaq: ... an update to Xpert® Carba-R, with the addition ... OXA-232.  The on-demand, molecular test also detects and ... carbapenem resistance, namely KPC, NDM, VIM, IMP-1 and ... as CROs or Superbugs, are a growing and ...
(Date:7/29/2015)... , July 29, 2015  Mylan N.V. (NASDAQ: ... clearance from the European Commission under the European Union ... Company plc (NYSE: PRGO ; TASE).  ... commented, "Today marks yet another important milestone in the ... as further affirmation of the sound industrial logic of ...
(Date:7/29/2015)... , July 29, 2015  Efforts to improve working ... of pharmaceutical firms in North America ... is that an effective working capital management will ease ... patent cliffs. Big pharma companies expect to invest in ... Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO Analysis ...
Breaking Medicine Technology:'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4
... Satellite Symposium -, SOUTH SAN FRANCISCO, Calif., ... ), a biopharmaceutical company focused,on oncology, today announced ... prostate cancer patients from its Phase 1 study ... 2008 Genitourinary (GU) Cancers,Symposium, a meeting of the ...
... a landmark study,electronically published today in the American ... test for detecting TB infection,QuantiFERON(R)-TB Gold (QFT(TM)), has ... the conventional tuberculin skin test (TST) at predicting,which ... TB,disease. This study has important implications for the ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 2Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 3Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 4Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 5Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 2Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 3Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 4
FLEXILOG spare part....
FLEXILOG spare part....
... are available from Oakfield for ... All buffers are suitable for ... external reference, single or multi-use ... in 250ml bottle and pH ...
... kit for convenient pH catheter calibration., ,pH ... any procedure. The Alpine Calibration kit contains ... water for your convenience. Simply cut the ... catheters to soak. No measuring or pouring! ...
Medicine Products: